Goldman Sachs removes Baxter International (BAX) from its Conviction Buy List after finding better opportunities in the healthcare sector. Analysts with the firm maintain their Buy rating, while clipping the price target on shares by a $1 to $59. Shares +0.4% premarket.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Feb 2, 2015)
at Investor's Business Daily (Jan 16, 2015)
at Investor's Business Daily (Jan 8, 2015)
at CNBC.com (Jan 6, 2015)
at Investor's Business Daily (Jan 5, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs